Constipation
| | |
Before ART
|
4/46 (8.7%)
|
4/4 (100%) grade 1
|
During ART
|
6/46 (13.0%)
|
6/6 (100%) grade 1
|
After ART1
|
6/46 (13.0%)
|
6/6 (100%) grade 1
|
Latest follow up2
|
5/37 (13.5%)
|
5/5 (100%) grade 1
|
Diarrhea
| | |
Before ART
|
4/46 (8.7%)
|
4/4 (100%) grade 1
|
During ART
|
20/46 (43.5%)
|
15/20 (75.0%) grade 1/5/20 (25.0%) grade 2
|
After ART1
|
11/46 (23.9%)
|
11/11 (100%) grade 1
|
Latest follow up2
|
4/37 (10.8%)
|
4/4 (100%) grade 1
|
Rectal bleeding
| | |
Before ART
|
3/46 (6.5%)
|
3/3 (100%) grade 1
|
During ART
|
2/46 (4.3%)
|
2/2 (100%) grade 1
|
After ART1
|
2/46 (4.3%)
|
2/2 (100%) grade 1
|
Latest follow up2
|
1/37 (2.7%)
|
1/1 (100%) grade 1
|
Nausea/Vomiting
| | |
Before ART
|
0/46 (0.0%)
|
-
|
During ART
|
4/46 (8.7%)
|
4/4 (100%) grade 1
|
After ART1
|
0/46 (0.0%)
|
-
|
Latest follow up2
|
0/37 (0.0%)
|
-
|
Haematuria
| | |
Before ART
|
2/46 (4.3%)
|
2/2 (100%) grade 1
|
During ART
|
6/46 (13.0%)
|
6/6 (100%) grade 1
|
After ART1
|
4/46 (8.7%)
|
4/4 (100%) grade 1
|
Latest follow up2
|
1/37 (2.7%)
|
1/1 (100%) grade 1
|
Urinary incontinence
| | |
Before ART
|
14/46 (30.4%)
|
12/14 (85.7%) grade 1/2/14 (14.3%) grade 2
|
During ART
|
17/46 (36.9%)
|
8/17 (47.1%) grade 1/9/17 (52.9%) grade 2
|
After ART1
|
16/46 (34.7%)
|
9/16 (56.3%) grade 1/7/16 (43.7%) grade 2
|
Latest follow up2
|
14/37 (37.8%)
|
10/14 (71.4%) grade 1/4/14 (28.6%) grade 2
|
Dysuria (urgency, feeling of obstruction, pain)
| | |
Before ART
|
4/46 (8.7%)
|
4/4 (100%) grade 1
|
During ART
|
7/46 (15.2%)
|
7/7 (100%) grade 1
|
After ART1
|
5/46 (10.9%)
|
5/5 (100%) grade 1
|
Latest follow up2
|
4/37 (10.8%)
|
4/4 (100%) grade 1
|
Skin Erythema in radiated region
| | |
Before ART
|
0/46 (0.0.%)
|
-
|
During ART
|
13/46 (28.3%)
|
13/13 (100%) grade 1
|
After ART1
|
9/46 (19.6%)
|
6/9 (66.7%) grade 1/3/9 (33.3%) grade 2
|
Latest follow up2
|
1/37 (2.7%)
|
1/1 (100%) grade 1
|
Skin hyperpigmentation in radiated region
| | |
Before ART
|
0/46 (0.0.%)
|
-
|
During ART
|
0/46 (0.0.%)
|
-
|
After ART1
|
6/46 (13.0%)
|
6/6 (100%) grad 1
|
Latest follow up2
|
3/37 (8.1%)
|
3/3 (100%) grade 1
|
Lymphedema extremity
| | |
Before ART
|
5/46 (10.9%)
|
5/5 (100%) grade 1
|
During ART
|
6/46 (13.0%)
|
6/6 (100%) grade 1
|
After ART1
|
6/46 (13.0%)
|
6/6 (100%) grade 1
|
Latest follow up2
|
5/37 (13.5%)
|
5/5 (100%) grade 1
|
Lymphocele
| | |
Before ART
|
2/46 (4.3%)
|
2/2 (100%) grade 1
|
During ART
|
3/46 (6.5%)
|
2/3 (66.7%) grade1/1/3 (33.3%) grade 2
|
After ART1
|
2/46 (4.3%)
|
2/2 (100%) grade 1
|
Latest follow up2
|
0/37 (0.0.%)
|
-
|
Paresthesia
| | |
Before ART
|
4/46 (8.7%)
|
4/4 (100%) grade 1
|
During ART
|
5/46 (10.9%)
|
5/5 (100%) grade 1
|
After ART1
|
5/46 (10.9%)
|
5/5 (100%) grade 1
|
Latest follow up2
|
5/37 (13.5%)
|
5/5 (100%) grade 1
|
Fatigue/exhaustion
| | |
Before ART
|
10/46 (21.7%)
|
10/10 (100%)
|
During ART
|
17/46 (37.0%)
|
17/17 (100%)
|
After ART1
|
16/46 (34.8%)
|
16/16 (100%)
|
Latest follow up2
|
9/37 (24.3%)
|
9/9 (100%)
|
Thrombosis
| | |
Before ART
|
0/46 (0.0.%)
|
-
|
During ART
|
0/46 (0.0.%)
|
-
|
After ART1
|
0/46 (0.0.%)
|
-
|
Latest follow up2
|
0/37 (0.0.%)
|
-
|
Embolism
| | |
Before ART
|
0/46 (0.0.%)
|
-
|
During ART
|
0/46 (0.0.%)
|
-
|
After ART1
|
0/46 (0.0.%)
|
-
|
Latest follow up2
|
0/37 (0.0.%)
|
-
|